Markets

European ADRs Edge Up as Pharma Stocks Gain

American depository receipts of European stocks were trading 0.1% higher at 145.50 on the Bank of New York Mellon Europe ADR Index on Wednesday.

Gainers in Continental Europe were led by clinical-stage biopharmaceutical company DBV Technologies ( DBVT ), 7.6% higher, followed by Dutch technology company ASML - New York Shares ( ASML ), up by 4.2% and genome engineering company Cellectis ( CLLS ), 4.1% higher.

In the UK, Adaptimmune Therapeutics ( ADAP ), a clinical-stage biopharmaceutical company, rose by 2.3% while telecommunication company BT Group ( BT ) increased by 1.3% and pharmaceutical company GW Pharmaceuticals (GWPH) lifted by 0.9%

Decliners in Continental Europe were led by ABB (ABB), a company engaged in power and automation technologies, down by 1.9%, followed by National Bank of Greece (NBG), 1.8% lower and ArcelorMittal (MT), a steel and mining company, down 1.7%

In the UK, biopharmaceutical company Amarin (AMRN) edged down by 1.2% while oil and gas production company Royal Dutch Shell - A shares (RDS.A) slid by 0.9% and gold mining company Randgold Resources (GOLD) edged 0.8% lower.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

DBVT ASML BT CLLS ADAP

Other Topics

Commodities